186 related articles for article (PubMed ID: 28483194)
1. Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.
Li X; Huang J; Kawamura A; Funakoshi R; Porcelli SA; Tsuji M
Vaccine; 2017 May; 35(24):3171-3177. PubMed ID: 28483194
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.
Li X; Kawamura A; Andrews CD; Miller JL; Wu D; Tsao T; Zhang M; Oren D; Padte NN; Porcelli SA; Wong CH; Kappe SH; Ho DD; Tsuji M
J Immunol; 2015 Sep; 195(6):2710-21. PubMed ID: 26254338
[TBL] [Abstract][Full Text] [Related]
3. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.
Coelho-Dos-Reis JG; Huang J; Tsao T; Pereira FV; Funakoshi R; Nakajima H; Sugiyama H; Tsuji M
Clin Immunol; 2016 Jul; 168():6-15. PubMed ID: 27132023
[TBL] [Abstract][Full Text] [Related]
5. A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.
Li X; Huang J; Kaneko I; Zhang M; Iwanaga S; Yuda M; Tsuji M
Expert Rev Vaccines; 2017 Jan; 16(1):73-80. PubMed ID: 27801602
[TBL] [Abstract][Full Text] [Related]
6. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
Bruna-Romero O; Schmieg J; Del Val M; Buschle M; Tsuji M
J Immunol; 2003 Mar; 170(6):3195-203. PubMed ID: 12626578
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
8. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates.
Padte NN; Boente-Carrera M; Andrews CD; McManus J; Grasperge BF; Gettie A; Coelho-dos-Reis JG; Li X; Wu D; Bruder JT; Sedegah M; Patterson N; Richie TL; Wong CH; Ho DD; Vasan S; Tsuji M
PLoS One; 2013; 8(10):e78407. PubMed ID: 24205224
[TBL] [Abstract][Full Text] [Related]
9. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
[TBL] [Abstract][Full Text] [Related]
11. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.
Gonzalez-Aseguinolaza G; Van Kaer L; Bergmann CC; Wilson JM; Schmieg J; Kronenberg M; Nakayama T; Taniguchi M; Koezuka Y; Tsuji M
J Exp Med; 2002 Mar; 195(5):617-24. PubMed ID: 11877484
[TBL] [Abstract][Full Text] [Related]
13. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
[TBL] [Abstract][Full Text] [Related]
14. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.
Padte NN; Li X; Tsuji M; Vasan S
Clin Immunol; 2011 Aug; 140(2):142-51. PubMed ID: 21185784
[TBL] [Abstract][Full Text] [Related]
16. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Liu Z; Bittman R; Jervis PJ; Cox LR; Besra GS; Wen X; Yuan W; Tsuji M; Li X; Ho DD; Chan J; Lee S; Frothingham R; Haynes BF; Panas MW; Gillard GO; Sixsmith JD; Korioth-Schmitz B; Schmitz JE; Larsen MH; Jacobs WR; Porcelli SA
PLoS One; 2014; 9(9):e108383. PubMed ID: 25255287
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice.
Schuldt NJ; Aldhamen YA; Godbehere-Roosa S; Seregin SS; Kousa YA; Amalfitano A
Malar J; 2012 Jun; 11():209. PubMed ID: 22720732
[TBL] [Abstract][Full Text] [Related]
18. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
[TBL] [Abstract][Full Text] [Related]
19. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.
Rodrigues EG; Zavala F; Eichinger D; Wilson JM; Tsuji M
J Immunol; 1997 Feb; 158(3):1268-74. PubMed ID: 9013969
[TBL] [Abstract][Full Text] [Related]
20. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
